Burning Rock narrows losses with drug research as new driver
The cancer testing company has finally reduced the flow of red ink and is generating a growing income stream from drug research services Key Takeaways: Burning Rock's net loss…
Recent Articles
RELATED ARTICLES
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US - FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
